Palvella Therapeutics, Inc. has announced the commencement of dosing in its Phase 3 SELVA trial, aimed at evaluating QTORIN™ ...

Studies have shown that Plan B and other oral contraceptives with levonorgestrel can be less effective in people who are ...

The unlisted ingredients can cause "life threatening" drops in blood pressure when used in combination with other prescription drugs.

Laser Photonics Corporation has acquired Control Micro Systems to expand its market reach into the pharmaceutical industry ... and capitalize on growing demand for laser-based drug delivery and ...

Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...

AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...

As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ramped up legal actions against its competitors. | As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ...

When patents for name brand medicines expire, the price of that medicine drops significantly as generic versions enter the market, but that process can take a while.

European Union antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings’ acquisition of contract drug ...

AI is revolutionizing spectroscopy by enhancing data analysis speed and accuracy, transforming applications in ...

Eli Lilly (NYSE:LLY) is a well-known pharmaceutical company out of Indianapolis ... Markets and Markets forecasts that GLP-1 drug market could be worth $471.1 billion by 2032, growing at a ...

the drug won’t be available on the NHS as it fails the test of being good value for money. The goal of every pharmaceutical company — and Britain punches well above its weight in this sector ...